NovelStem International Corp. (NSTM)
- Previous Close
0.0240 - Open
0.0120 - Bid 0.0201 x --
- Ask 0.0240 x --
- Day's Range
0.0119 - 0.0240 - 52 Week Range
0.0100 - 0.0700 - Volume
277,000 - Avg. Volume
10,916 - Market Cap (intraday)
937,630 - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 2, 2018
- 1y Target Est
--
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
www.novelstem.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NSTM
View More
Performance Overview: NSTM
Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NSTM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NSTM
View MoreValuation Measures
Market Cap
1.13M
Enterprise Value
5.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
93.76
Price/Book (mrq)
--
Enterprise Value/Revenue
461.42
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--